JUNE, 2012 Gene-Related Patents Issued - Full patent | ||||
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,206,932 | Antibodies and related molecules that bind to PSCA proteins | Agensys, Inc. | 26-Jun-12 | United States |
8,192,963 | Bacterium capable of producing L-amino acid and method for producing L-amino acid | Ajinomoto Co., Inc. | 5-Jun-12 | Japan |
8,192,953 | Trimerising module | Anaphore, Inc. | 5-Jun-12 | United States |
8,206,950 | Fusion antigen used as vaccine and method of making them | Animal Technology Institute Taiwan | 26-Jun-12 | Taiwan |
8,192,933 | Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) | Athena Diagnostics, Inc | 5-Jun-12 | United States |
8,206,906 | Methods and compositions for analyzing AHASL genes | BASF SE | 26-Jun-12 | Germany |
8,206,953 | Message abundance and allele copy number determination using IVT with single-stranded primer-promoter-selector constructs | BioArray Solutions, Ltd. | 26-Jun-12 | United States |
8,206,965 | Hybrid and single chain meganucleases and use thereof | Cellectis S.A. | 26-Jun-12 | France |
8,198,061 | Acetylcholinesterase gene responsible for insecticide resistance and applications thereof | Centre National de la Recherche Scientifique | 12-Jun-12 | France |
8,198,064 | Mutant bacterial strains of the genus sphingomonas deficient in production of polyhydroxybutyrate and a process of clarification of sphingans and compositions thereof | CP Kelco U.S., Inc. | 12-Jun-12 | United States |
8,192,962 | Processes for detecting toxic substances | Daikin Industries, Ltd. | 5-Jun-12 | Japan |
8,202,704 | Trichoderma genes | Danisco US Inc | 19-Jun-12 | United States |
8,192,931 | Method to detect prostate cancer in a sample | DiagnoCure Inc. | 5-Jun-12 | Canada |
8,206,922 | Methods of detecting charcot-marie tooth disease type 2A | Duke University | 26-Jun-12 | United States |
8,206,964 | Perhydrolase providing improved specific activity | E. I. du Pont de Nemours and Company | 26-Jun-12 | United States |
8,206,963 | Perhydrolase providing improved peracid stability | E. I. du Pont de Nemours and Company | 26-Jun-12 | United States |
8,198,081 | Dopaminergic neuron progenitor cell marker 187A5 | Eisai R&D Management Co., Ltd. | 12-Jun-12 | Japan |
8,192,934 | Method for delivering nucleic acid into eukaryotic genomes | Finnzymes Oy | 5-Jun-12 | Finland |
8,206,919 | Gene expression markers for breast cancer prognosis | Genomic Health, Inc. | 26-Jun-12 | United States |
8,202,690 | Cancer marker and therapeutic agent for cancer | Hisamitsu Pharmaceutical Co., Inc. | 19-Jun-12 | Japan |
8,202,718 | Ecdysone receptor-based inducible gene expression system | Intrexon Corporation | 19-Jun-12 | United States |
8,192,973 | Detection of mutations in a gene associated with resistance to viral infection, OAS1 | Kineta Two, LLC | 5-Jun-12 | United States |
8,206,961 | Modified Luciola cruciata luciferase protein | Marker Gene Technologies, Inc. | 26-Jun-12 | United States |
8,206,925 | Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseases | Medical Diagnostic Laboratories, LLC | 26-Jun-12 | United States |
8,206,930 | Compositions and methods for detecting Borrelia afzelii | Medical Diagnostics Laboratories, LLC | 26-Jun-12 | United States |
8,206,899 | Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms | Philadelphia Health and Education Corporation | 26-Jun-12 | United States |
8,206,898 | RNA exit channel: target and method for inhibition of bacterial RNA polymerase | Rutgers, The State University of New Jersey | 26-Jun-12 | United States |
8,192,932 | Covalent joining of DNA strands to RNA strands catalyzed by vaccinia topoisomerase | Sloan-Kettering Institute For Cancer Research | 5-Jun-12 | United States |
8,206,928 | Method for determination of presence of crossing with cultivated rose in wild rose | Suntory Holdings Limited | 26-Jun-12 | Japan |
8,198,052 | Primers for nucleic acid amplification in detecting .beta.-actin and test method using these primers | Sysmex Corporation | 12-Jun-12 | Japan |
8,192,938 | Methods for quantifying microRNA precursors | The Ohio State University | 5-Jun-12 | United States |
8,192,991 | Methods of eliciting or boosting a cellular immune response | The Regents of the University of California | 5-Jun-12 | United States |
8,202,692 | Expression profile of thyroid cancer | The Regents of the University of Michigan | 19-Jun-12 | United States |
8,192,945 | Method for screening compounds to determine those which enhance islet cell activity and/or survival and uses therefor | The Salk Institute for Biological Studies | 5-Jun-12 | United States |
8,192,929 | Assay system for monitoring the effects of genetically engineered cells to alter function of a synctium | The Trustees of Columbia University in the City of New York | 5-Jun-12 | United States |
8,193,163 | Compositions and methods for siRNA inhibition of ICAM-1 | The Trustees of the University of Pennsylvania | 5-Jun-12 | United States |
8,192,928 | Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease | Wake Forest University Health Sciences | 5-Jun-12 | United States |
8,198,089 | Flocculent yeast and method for production thereof | Yamaguchi University | 12-Jun-12 | Japan |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,202,845 | Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification | Acuity Pharmaceuticals, Inc. | 19-Jun-12 | United States |
8,197,818 | EML4-ALK fusion gene | Astellas Pharma Inc. | 12-Jun-12 | Japan |
8,197,823 | Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof | China Animal Disease Control Center | 12-Jun-12 | China P. Rep. |
8,202,846 | Methods and compositions for RNA interference | Cold Spring Harbor Laboratory | 19-Jun-12 | United States |
8,193,155 | Method and compositions for treating skin | ELC Management, LLC | 5-Jun-12 | United States |
8,197,825 | Recombinant MVA virus and the use thereof | GSF-Forschungszentrum fur Umwelt und Gesundheit GmbH | 12-Jun-12 | Germany |
8,197,820 | HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination | Istituto Superiore di Sanita | 12-Jun-12 | Italy |
8,206,721 | Use of an extract from snow algae in cosmetic or dermatological formulations | Mibelle AG | 26-Jun-12 | Switzerland |
8,193,161 | Compositions comprising cardiac stem cells overexpressing specific micrornas and methods of their use in repairing damaged myocardium | New York Medical College | 5-Jun-12 | United States |
8,198,259 | Treatment of neurological disorders by dsRNA administration | Novartis AG | 12-Jun-12 | Switzerland |
8,198,258 | Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases | Quark Pharmaceuticals Inc. | 12-Jun-12 | United States |
8,193,168 | Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release | Redpoint Bio Corporation | 5-Jun-12 | United States |
8,193,160 | System for inhibiting pathogenicity in the rice-blast fungus Magnaporthe grisea | Temasek Life Sciences Laboratory | 5-Jun-12 | Singapore |
8,207,120 | NELL-1 enhanced bone mineralization | The Regents of the University of California | 26-Jun-12 | United States |
8,198,236 | Methods and compositions for the treatment of cancer | Washington University | 12-Jun-12 | United States |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,207,403 | EPSP synthase with high glyphosate resistance and its encoded sequence | Biotechnology Research Institute The Chinese Academy of Agricultural Sciences | 26-Jun-12 | China P. Rep. |
8,207,396 | Gene disruptions, compositions and methods relating thereto | Genentech, Inc. | 26-Jun-12 | United States |
8,198,507 | Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines | Institut National de la Sante Et de la Recherche Medicale - INSERM | 12-Jun-12 | France |
8,207,401 | A method of creating a plant improved in tolerance to iron deficiency | Japan Science and Technology Agency | 26-Jun-12 | Japan |
8,193,413 | Temporal seed promoters for expressing genes in plants | Monsanto Technology LLC | 5-Jun-12 | United States |
8,203,032 | Application of fluorescent protein to garden plant | NEC Soft, Ltd. | 19-Jun-12 | Japan |
8,193,411 | Marker mapping and resistance gene associations in soybean | Pioneer Hi-Bred International, Inc. | 5-Jun-12 | United States |
8,193,408 | Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of a nematode gene | Sanofi-Aventis Deutschland GmbH | 5-Jun-12 | Germany |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,202,966 | Human Dickkopf-related protein and nucleic acid molecules and uses therefor | Millennium Pharmaceuticals, Inc. | 19-Jun-12 | United States |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,202,980 | Method and medicament for inhibiting the expression of a given gene | Alnylam Pharmaceuticals, Inc. | 19-Jun-12 | United States |
8,207,319 | Probe, probe set, probe-immobilized carrier, and genetic testing method | Canon Kabushiki Kaisha | 26-Jun-12 | Japan |
8,207,317 | Probe, probe set, probe-immobilized carrier, and genetic testing method | Canon Kabushiki Kaisha | 26-Jun-12 | Japan |
8,198,427 | SiRNA targeting catenin, beta-1 (CTNNB1) | Dharmacon, Inc. | 12-Jun-12 | United States |
8,193,332 | Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes | Genecare Research Institute Co., Ltd. | 5-Jun-12 | Japan |
8,202,977 | Pestivirus species | Minister for Primary Industries for and on behalf of the State of New South Wales | 19-Jun-12 | Australia |
8,193,328 | Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents | Philadelphia Health & Education Corporation | 5-Jun-12 | United States |
8,207,140 | Oligomeric compounds for the modulation of HIF-1.alpha. expression | Santaris Pharma A/S | 26-Jun-12 | Denmark |
8,202,979 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid | Sirna Therapeutics, Inc. | 19-Jun-12 | United States |
8,207,320 | Lipase | Suntory Holdings Limited | 26-Jun-12 | Japan |
8,193,334 | Polymer-encapsulated reverse micelles | The Brigham and Women's Hospital | 5-Jun-12 | United States |
8,198,254 | Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer | The Regents of the University of California | 12-Jun-12 | United States |
8,207,321 | Method of obtaining idolocarbazoles using biosynthetic rebeccamycin genes | Universidad De Oviedo | 26-Jun-12 | Spain |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.